Drugs - Real World Outcomes

Acknowledgement to Referees

Associations Between Anticholinergic Medication Exposure and Adverse Health Outcomes in Older People with Frailty: A Systematic Review and Meta-analysis

David Mehdizadeh, Matthew Hale, Oliver Todd, Hadar Zaman, Iuri Marques, Duncan Petty, David P. Alldred, Owen Johnson, Muhammad Faisal, Peter Gardner, Andrew Clegg

Current Status, Challenges, and Future Perspectives of Real-World Data and Real-World Evidence in Japan

Katsutoshi Hiramatsu, Annabel Barrett, Yasuhiko Miyata

Stroke Risk Among Non-Elderly Users of Haloperidol or First-Generation Antipsychotics vs Second-Generation Antipsychotics: A Cohort Study from a US Health Insurance Claims Database

Daniel Fife, Clair Blacketer, Karl Knight, James Weaver

Retrospective Claims Analysis of Treatment Patterns, Relapse, Utilization, and Cost Among Patients with Multiple Sclerosis Initiating Second-Line Disease-Modifying Therapy

Leorah Freeman, Arianna Kee, Marc Tian, Rina Mehta

Real-World Clinical Use and Outcomes of Telavancin for the Treatment of Bone and Joint Infections: Results from the Telavancin Observational Use Registry (TOUR™)

Charles R. Sims, Adam M. Bressler, Donald R. Graham, Melinda K. Lacy, David A. Lombardi, Bibiana Castaneda-Ruiz

Potentially Inappropriate Medication Use in Older Adults with Alzheimer’s Disease and Related Dementias Living in the Community: A Cross-Sectional Analysis

Lauren E. Vickers, Ashley I. Martinez, Alexandra M. Wallem, Clare Johnson, Daniela C. Moga

Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Real Life: One-Year Clinical and Economic Outcomes

Romain Giraud, Nicolas Delmotte, Sophie Gensollen, Martine Roche, Céline Falaise, Hervé Chambost, Manon Roche

European and US Real-World Treatment Patterns in Patients with Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A Retrospective Medical Record Review

Riyaz Shah, Nicolas Girard, Saurabh P. Nagar, Frank Griesinger, Julia Roeper, Keith L. Davis, Parisa Karimi, William Sawyer, Ning Yu, Aliki Taylor, Josephine Feliciano

Risk of Bleeding Associated with Antidepressant Drugs: The Competitive Impact of Antithrombotics in Quantitative Signal Detection

René Zeiss, Christoph Hiemke, Carlos Schönfeldt-Lecuona, Bernhard J. Connemann, Maximilian Gahr

Factors Associated with Hyponatremia in Patients Newly Prescribed Citalopram: A Retrospective Observational Study

Andrea Christine Shysh, Zahinoor Ismail, Davinder Sidhu, Maggie Guo, Leonard T. Nguyen, Christopher Naugler

Real-World Persistence, Maintenance Dosing, and Pre-Post Corticosteroid and Opioid Use Among Crohn’s Disease Patients with Prescription Claims for Ustekinumab in the USA

Zhijie Ding, Camilo Obando, Erik Muser, Chris Kozma, Terra Slaton

Comparison Between Health Insurance Claims and Electronic Health Records (EHRs) for Metastatic Non-small-cell Lung Cancer (NSCLC) Patient Characteristics and Treatment Patterns: A Retrospective Cohort Study

Yookyung Christy Choi, Dongmu Zhang, Jerzy E. Tyczynski

Safety of Anthroposophic Medicinal Products: An Analysis of Adverse Drug Reactions from German Pharmacovigilance Databases

Miek C. Jong, Herman van Wietmarschen, Anja Glockmann, Erik W. Baars, Harald J. Hamre

Anticoagulation in Very Old Patients with Atrial Fibrillation (AVOPA): A Descriptive Observational Study

Maximilian Hupfer, Markus Gosch